Label: BRIM-DOR PF- brimonidine - dorzolamide pf solution/ drops

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated May 8, 2018

If you are a consumer or patient please visit this version.

  • STORAGE AND HANDLING

    Store at 20° to 25° C (68° to 77° F)

    Close
  • Bottle Label
  • INGREDIENTS AND APPEARANCE
    BRIM-DOR PF 
    brimonidine - dorzolamide pf solution/ drops
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70261-518
    Route of Administration OPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BRIMONIDINE TARTRATE (UNII: 4S9CL2DY2H) (BRIMONIDINE - UNII:E6GNX3HHTE) BRIMONIDINE 1.5 mg  in 1 mL
    DORZOLAMIDE HYDROCHLORIDE (UNII: QZO5366EW7) (DORZOLAMIDE - UNII:9JDX055TW1) DORZOLAMIDE 20 mg  in 1 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:70261-518-10 10 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product 01/01/2018
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    unapproved drug other 01/01/2018
    Labeler - ImprimisRx NJ (931390178)
    Close